ShangPharma Innovation portfolio company Tilos Therapeutics acquired for up to $773 Million by Merck

Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast as it looks to help early-stage biomedical work get off the ground with more lab space.